These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2836656)

  • 21. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system.
    Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP
    Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural differences between the glucocorticoid, dioxin and oxysterol receptors from rat liver cytosol.
    Denis M; Wilhelmsson A; Cuthill S; Poellinger L; Gustafsson JA
    Biochem Biophys Res Commun; 1989 Aug; 163(1):444-51. PubMed ID: 2549994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-affinity aldosterone binding in rat liver--a re-evaluation.
    Zaini A; Pearce P; Funder JW
    Clin Exp Pharmacol Physiol; 1987 Jan; 14(1):39-45. PubMed ID: 2955977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postnatal development and environmental regulation of hippocampal glucocorticoid and mineralocorticoid receptors.
    Sarrieau A; Sharma S; Meaney MJ
    Brain Res; 1988 Sep; 471(1):158-62. PubMed ID: 2851372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippocampal and renal type I receptors are differentially regulated.
    Stephenson G; Funder J
    Am J Physiol; 1987 Apr; 252(4 Pt 1):E525-9. PubMed ID: 3031992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical characterization of glucocorticoid receptors of rat testis.
    Kalimi M; Shen J; Hubbard J
    J Steroid Biochem; 1983 Sep; 19(3):1265-72. PubMed ID: 6621035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an exchange assay for cytosolic glucocorticoid receptors using the synergistic effects of molybdate plus dithiothreitol.
    Kalimi M; Hubbard JR
    Endocrinology; 1983 Sep; 113(3):1161-3. PubMed ID: 6872954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mineralocorticoid specificity of renal type I receptors: binding and metabolism of corticosterone.
    Doyle D; Smith R; Krozowski ZS; Funder JW
    J Steroid Biochem; 1989 Aug; 33(2):165-70. PubMed ID: 2549303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type I receptors in parotid, colon, and pituitary are aldosterone selective in vivo.
    Sheppard K; Funder JW
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E467-71. PubMed ID: 2821824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo competitive autoradiographic study of [3H]corticosterone and [3H]aldosterone binding sites within mouse brain hippocampus.
    Coutard M; Duval D; Osborne-Pellegrin MJ
    J Steroid Biochem; 1987 Jul; 28(1):29-34. PubMed ID: 2956460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary.
    Reul JM; de Kloet ER; van Sluijs FJ; Rijnberk A; Rothuizen J
    Endocrinology; 1990 Aug; 127(2):907-15. PubMed ID: 2164924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the rat kidney mineralocorticoid receptor.
    Eisen LP; Harmon JM
    Endocrinology; 1986 Oct; 119(4):1419-26. PubMed ID: 3019632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rat C6 glioma cells contain type I as well as type II corticosteroid receptors.
    Beaumont K
    Brain Res; 1985 Sep; 342(2):252-8. PubMed ID: 4041825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
    Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
    Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippocampal cytosol binding capacity of corticosterone: no depletion with nuclear loading.
    Turner BB; McEwen BS
    Brain Res; 1980 May; 189(1):169-82. PubMed ID: 7363083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenal steroid type I and type II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying level of steroid.
    Spencer RL; Young EA; Choo PH; McEwen BS
    Brain Res; 1990 Apr; 514(1):37-48. PubMed ID: 2357528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in the binding of type I and type II corticosteroid receptors in rat hippocampus.
    Turner BB
    Brain Res; 1992 May; 581(2):229-36. PubMed ID: 1393531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticosteroid binding in rat brain and pituitary cytosols: resolution of multiple binding components by polyacrylamide gel based isoelectric focusing.
    MacLusky NJ; Turner BB; McEwen BS
    Brain Res; 1977 Jul; 130(3):564-71. PubMed ID: 890453
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of mineralocorticoid binding sites in rat brain by competition studies and density gradient centrifugation.
    Coirini H; Marusic ET; De Nicola AF; Rainbow TC; McEwen BS
    Neuroendocrinology; 1983 Nov; 37(5):354-60. PubMed ID: 6316188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endotoxin and interleukin 1 decrease the affinity of hippocampal mineralocorticoid (type I) receptor in parallel to activation of the hypothalamic-pituitary-adrenal axis.
    Schöbitz B; Sutanto W; Carey MP; Holsboer F; de Kloet ER
    Neuroendocrinology; 1994 Aug; 60(2):124-33. PubMed ID: 7969769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.